Brickell Biotech to sell additional $15M worth of stock as critical clinical trial begins

Posted on October 13, 2020 by admin in Uncategorized

BOULDER — Brickell Biotech Inc. (Nasdaq: BBI) is planning to raise an additional $15 million via new stocks and warrants […]
Source: BizWest

beach